TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.

Alvaro Moreno-Aspitia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.